Idealized Approach to the Optimal Design, Development and Evaluation of Drug Delivery Systems I: Drug Bioavailability Input-Pharmacological Response Output Relationships
- 1 January 1974
- journal article
- research article
- Published by Taylor & Francis in Drug Development Communications
- Vol. 1 (2) , 143-172
- https://doi.org/10.3109/03639047409088173
Abstract
The marketing of drug delivery systems possessing an optimal therapeutic utility is the principal concern of the drug industry. It is necessary and useful in systematically pursuing the rational design and development of optimal drug delivery systems, to establish performance criteria upon which to base their evaluation and gauge the success of these efforts at any stage of the development. This first communication discusses the drug bioavailability input-pharmacological response output relationships which provide the means for establishing such guidelines. Part II discusses the application of these relationships and presents a rational, although idealized, approach to the development of drug products designed to elicit optimally sought pharmacological response behavior. The role of a new method of in-vitro drug product testing which is optimally predictive of in-vivo bioavailability, is presented. Examples are drawn from ongoing research in the authors' laboratories. The limitations within which the general ideals of ultimately optimal behavior of drug delivery systems are applicable and practical to achieve are discussed.Keywords
This publication has 11 references indexed in Scilit:
- Drug bioavailability and pharmacokinetic analysis from pharmacological dataJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Multiple-Dose Kinetics of Pharmacological Effects of Indirect AnticoagulantsJournal of Pharmaceutical Sciences, 1972
- Relationship between Dose, Effect, Time, and Biophasic Drug LevelsJournal of Pharmaceutical Sciences, 1972
- Drug Input Optimization: Bioavailability-Effected Time-Optimal Control of Multiple, Simultaneous, Pharmacological Effects and Their InterrelationshipsJournal of Pharmaceutical Sciences, 1972
- Drug-Absorption Analysis from Pharmacological Data II: Transcorneal Biophasic Availability of TropicamideJournal of Pharmaceutical Sciences, 1971
- Determination of Time Course of In Vivo Pharmacological Effects from In Vitro Drug-Release TestingJournal of Pharmaceutical Sciences, 1971
- Quantitative Determination of Drug Bioavailability and Biokinetic Behavior from Pharmacological Data for Ophthalmic and Oral Administrations of a Mydriatic DrugJournal of Pharmaceutical Sciences, 1971
- Radioassay of chlorpromazine and its metabolites in plasmaPsychopharmacology, 1971
- Drug-Absorption Analysis from Pharmacological Data I: Method and Confirmation Exemplified for the Mydriatic Drug TropicamideJournal of Pharmaceutical Sciences, 1971
- Studies of delayed‐action medication V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazineClinical Pharmacology & Therapeutics, 1970